TSX closed
Loading markets…

Advertisement

Stocks/TSX/CRDL

Cardiol Therapeutics Inc Class A (CRDL : TSX)

Common Stock

$1.71

CAD

+0.08 (4.91%)

Last updated: 2026-07-30

Get CRDL alerts:

CRDL

Cardiol Therapeutics Inc Class A

Source:WealthAwesomeWealthAwesome
$0.21 (14.00%)
30 day period
$1.44$1.63$1.82Jun 18Jul 10Jul 30

Performance

1 Day

+4.91%

1 Week

-1.72%

1 Month

+14.77%

YTD

+25.74%

Key Statistics

Market Cap

$187.89M

52W High

$2.33

52W Low

$1.23

P/E Ratio

-

50 Day MA

$1.60

200 Day MA

$1.55

Beta

0.51

Dividend Yield

-

Advertisement

Technical Indicators

Price vs 50-Day SMA

Above 50 SMA

Price vs 200-Day SMA

Above 200 SMA

Recent Price History

DateOpenHighLowCloseAdj CloseVolume
7/30/2026$1.65$1.73$1.61$1.71$1.71138,783
7/29/2026$1.68$1.70$1.61$1.63$1.6389,426
7/28/2026$1.64$1.72$1.57$1.70$1.70165,965
7/27/2026$1.68$1.70$1.63$1.64$1.64111,361
7/24/2026$1.74$1.74$1.64$1.67$1.6791,829
7/23/2026$1.79$1.85$1.72$1.74$1.74104,939
7/22/2026$1.79$1.82$1.74$1.82$1.82110,138
7/21/2026$1.76$1.82$1.73$1.77$1.7794,737
7/20/2026$1.76$1.81$1.65$1.75$1.75136,772
7/17/2026$1.74$1.74$1.65$1.69$1.69112,633

Analyst Price Targets

Based on analyst covering CRDL

📈

Wall Street analysts forecast CRDL stock price to rise 250.9% over the next 12 months.

Consensus

Bullish

Based on avg. target vs last close (formal rating unavailable for Canadian listings)

Avg. Target

C$6.00

+250.9% Upside

Current Price

C$1.71

Last close

Compare analyst targets across the TSX & TSXV →

Analyst ratings and price targets are updated periodically. Not financial advice.

Wealth Awesome Price Forecast

WA Model

Statistical 90-day price range based on CRDL's historical volatility

HistoricalForecast68%95%
C$0.80C$1.27C$1.74C$2.21C$2.67C$3.14TodayMar 24May 28Jul 30Sep 11Oct 25Dec 7

30-Day Vol

54.9%

Annualized

90-Day Vol

59.7%

Annualized

Trend (90d)

-21.5%

Annualized drift

90d Mean

C$1.58

Expected price

HorizonExpected68% Range (1σ)
30 trading daysC$1.67C$1.38C$2.01
60 trading daysC$1.62C$1.24C$2.12
90 trading daysC$1.58C$1.14C$2.20

Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.

About Cardiol Therapeutics Inc Class A

Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the development of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases. Its lead product candidate is CardiolRx, which is in Phase III multi-national, randomized, double-blind, and placebo-controlled study to evaluate the efficacy and safety of CardiolRx in acute myocarditis, as well as for the treatment of recurrent pericarditis. The company is also developing CRD-38, a novel subcutaneously administered drug formulation of cannabidiol for the treatment of heart failure. Cardiol Therapeutics Inc. was incorporated in 2017 and is headquartered in Oakville, Canada.

Financials

Revenue (TTM)
$0
EBITDA
$-35.57M
Profit Margin
0.00%
ROE (TTM)
-173.96%
EPS (Diluted)
-0.39
Book Value
0.22

Classification

Sector
Health Care
Industry
Pharmaceuticals
Group
Pharmaceuticals, Biotechnology & Life Sciences

7 stocks to buy and hold forever

Blue-chip dividend stocks for long-term wealth building.

Get the FREE Report

Advertisement

Common Questions About CRDL

Market movers

Recent TSX movers

Top 1-day gainers — updated from our Canadian movers feed.

All movers →
TickerNamePrice1D
APLIAppili Therapeutics Inc$0.01+50.00%
BHCBausch Health Companies Inc$8.43+28.51%
KEELKeel Infrastructure Corp.$5.64+26.74%
HUTHut 8 Mining Corp$151.68+22.39%
HIVEHIVE DIGITAL TECHNOLOGIES LTD$4.21+18.59%
IVQInvesque Inc$0.14+17.39%
SSherritt International Corporation$0.14+16.67%
PNC-APostmedia Network Canada Corp$0.99+16.47%

CRDL.TO news timeline

15 articles covering CRDL.TO, most recent first

Latest

Why Cardiol Therapeutics Inc Class A stock is rising today

Stocks

Advertisement